Showing results (41-50 of 202) with videos related to

Sort By:
Pageof 21
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2004
Hypertension in HIV-1-infected patients and its impact on renal and cardiovascular integrityOliver Jung, Markus Bickel, Tilmann Ditting, et al.
AIDS (London, England)|September 26, 2009
Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patientsGerd Fätkenheuer, Schlomo Staszewski, Andreas Plettenburg, et al.
Antiviral Therapy|December 3, 2008
Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapyAnna M Geretti, Colette Smith, Annette Haberl, et al.
Biometrics|July 19, 2013
Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching timesBrent A Johnson, Heather Ribaudo, Roy M Gulick, et al.
AIDS (London, England)|October 28, 2005
The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjectsDavid B Clifford, Scott R Evans, Yijun Yang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 8, 2003
Brief report: efficacy and treatment-limiting toxicity with the concurrent use of lopinavir/ritonavir and a third protease inhibitor in treatment-experienced HIV-infected patientsNathalie C Casau, Marshall J Glesby, Simon Paul, et al.
Sexually Transmitted Diseases|June 10, 2010
Prevalence- and gender-specific immune response to opportunistic infections in HIV-infected patients in LesothoHolger F Rabenau, Tessa Lennemann, Claudia Kircher, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 2005
Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre studyHassane Izzedine, Jean Sebastien Hulot, Daniel Vittecoq, et al.
HIV Clinical Trials|April 20, 2010
Vicriviroc and peripheral neuropathy: results from AIDS Clinical Trials Group 5211Tzu-min Yeh, Scott R Evans, Roy M Gulick, et al.
Rheumatology Advances in Practice|April 20, 2021
Failure of chronic hydroxychloroquine in preventing severe complications of COVID-19 in patients with rheumatic diseasesKhanh Pham, Heidi Torres, Michael J Satlin, et al.
Pageof 21